LNTHのニュース
Truist Securities maintains Lantheus Holdings Inc at Buy with a price target of $125.00 2023/05/05 17:08:37 Investing.com
https://www.investing.com/news/pro/lantheus-holdings-inc-receives-investment-bank-analyst-rating-update-3074690
JMP Securities maintains Lantheus Holdings Inc at Market Outperform with a price target of $130.00 2023/05/05 06:53:37 Investing.com
https://www.investing.com/news/pro/lantheus-holdings-inc-receives-investment-bank-analyst-rating-update-3073977
Lantheus Holdings, Inc. (LNTH) Q1 2023 Earnings Call Transcript 2023/05/04 23:06:17 Seeking Alpha
Lantheus Holdings, Inc. (NASDAQ:NASDAQ:LNTH) Q1 2023 Results Conference Call May 4, 2023 8:00 AM ETCompany ParticipantsMark Kinarney - Vice President of Investor RelationsMary Anne Heino -…
Lantheus Holdings: Building A Sales Juggernaut 2023/05/04 19:43:07 Seeking Alpha
Lantheus Holdings reported stellar quarterly results once again for Q1 2023 and raised guidance significantly as well. Click here to read my earnings analysis of LNTH stock.
Stock Market Off Lows Ahead Of Apple And Jobs; Prostate Cancer Stock Jumps 15% After Earnings 2023/05/04 19:27:10 Investor''s Business Daily
Lantheus shares surged on positive buzz for their PET imaging detection agent for prostate cancer.
Analysts Predict A Surge In Lantheus Holdings Inc. (NASDAQ: LNTH)? 2022/12/31 12:00:00 Stocks Register
Lantheus Holdings Inc. (NASDAQ:LNTH) shares, rose in value on Friday, 12/30/22, with the stock price up by 0.67% to the previous day’s close as strong demand from buyers drove the stock to $50.96. Actively observing the price movement in the last trading, the stock closed the session at $50.62, falling within a range of $49.76 … Analysts Predict A Surge In Lantheus Holdings Inc. (NASDAQ: LNTH)? Read More »
POINT Biopharma Announces Closing of Agreements with Lantheus Holdings 2022/12/20 13:30:00 GlobeNewswire
INDIANAPOLIS, Dec. 20, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (“POINT”) (NASDAQ: PNT), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced that the closing conditions, including Hart-Scott-Rodino antitrust clearance, have been met for the previously announced agreements with Lantheus Holdings Inc. (NASDAQ: LNTH).
Lantheus prices $500M convertible senior notes 2022/12/06 13:24:48 Seeking Alpha
Lantheus Holdings (LNTH) priced a $500M convertible senior notes due 2027.
Lantheus Holdings, Inc. Announces Pricing of Offering of $500 Million Convertible Senior Notes due 2027 2022/12/06 12:45:00 GlobeNewswire
NORTH BILLERICA, Mass., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company” or “Lantheus”) (NASDAQ: LNTH), today announced the pricing of $500 million in aggregate principal amount of the Company’s convertible senior notes due 2027 (the “Notes”). The Notes are being sold only to persons reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Company also granted the initial purchasers of the Notes an option to purchase, within the 13-day period beginning on, and including, the initial closing date of the offering, up to an additional $75 million in aggregate principal amount of Notes. The sale of the Notes to the initial purchasers is expected to settle on or about December 8, 2022, subject to customary closing conditions, and is expected to result in approximately $485 million in net proceeds to the Company (assuming no exercise by the initial purchasers of their option to purchase additional notes), after deducting the initial purchaser’s discount and estimated offering expenses payable by the Company.
Lantheus Holdings Stock Showing Market Leadership; Earns 94 RS Rating 2022/11/29 19:46:00 Investor''s Business Daily
Lantheus Holdings shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Lantheus Holdings Stock Showing Market Leadership; Earns 94 RS Rating 2022/11/29 19:46:00 Investor''s Business Daily
Lantheus Holdings shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Lantheus: Sell Thesis Missing These Key Factors 2022/11/29 06:28:52 Seeking Alpha
Lantheus Holdings is a name we’ve scaled into this year and we’re here today to outline the findings of our risk/reward calculus. Read to learn more about LNTH.
LNTH stock up on approval for ultrasound enhancing agent in China (NASDAQ:LNTH) 2022/11/28 17:05:19 Seeking Alpha
U.S. healthcare supplier Lantheus Holdings, Inc. (LNTH) announced Monday that regulators in China approved an import drug license for its ultrasound-enhancing agent marketed as Definity
Lantheus Holdings: May Be Time To Buy After Big Correction (NASDAQ:LNTH) 2022/11/28 07:29:54 Seeking Alpha
Lantheus Holdings share price finally started to correct afer two years of continuous upward movement. Find out if LNTH stock has any gas left in the tank.
Lantheus Holdings Inc. (NASDAQ:LNTH) Drops -0.53%, But Further Rally Could Be Imminent 2022/11/26 21:00:00 Marketing Sentinel
In last trading session, Lantheus Holdings Inc. (NASDAQ:LNTH) saw 0.32 million shares changing hands with its beta currently measuring 0.76. Company’s recent per share price level of $58.45 trading at -$0.31 or -0.53% at ring of the bell on the day assigns it a market valuation of $3.84B. That closing price of LNTH’s stock is … Lantheus Holdings Inc. (NASDAQ:LNTH) Drops -0.53%, But Further Rally Could Be Imminent Read More »